Novonesis price target raised to DKK 545 from DKK 520 at JPMorgan
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 05 2025
0mins
Source: Business Insider
JPMorgan's Price Target Update: JPMorgan has increased its price target for Novozymes (NVZMY) from DKK 520 to DKK 545 while maintaining an Overweight rating on the shares.
Investment Opportunities: TipRanks offers tools for investors to discover stocks with Strong Buy ratings and optimize their portfolios through a stock screener.
Get Free Real-Time Notifications for Any Stock
Monitor tickers like undefined with instant alerts to capture every critical market movement.
Sign up for free to build your custom watchlist and receive professional-grade stock notifications.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
